ATXI - Avenue Therapeutics drops 9% on 1-for-75 reverse split April, 24 2024 07:58 AM Avenue Therapeutics Inc. 2024-04-24 07:58:30 ET More on Avenue Therapeutics Avenue Therapeutics granted extension for Nasdaq compliance Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenue Therapeutics Financial information for Avenue Therapeutics For further details see: Avenue Therapeutics drops 9% on 1-for-75 reverse split